Tenax Therapeutics, Inc.

Contributing Author

Recent Articles by Tenax Therapeutics, Inc.

14 hours	Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment TENX +5.65% GlobeNewswire
Nov-25	Tenax Therapeutics to Participate in Upcoming Investor Conferences TENX GlobeNewswire
Nov-12	Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update TENX GlobeNewswire
Nov-06	Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 (Oral Levosimendan) for the Treatment of PH-HFpEF TENX GlobeNewswire
Nov-03	Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference TENX GlobeNewswire
Sep-16	Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF TENX GlobeNewswire
Aug-28	Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025 TENX GlobeNewswire
Aug-13	Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update TENX GlobeNewswire
May-14	Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update TENX GlobeNewswire